Predictors of prolonged progression-free survival in patients with unresectable or recurrent pancreatic cancer treated with nanoliposomal irinotecan with fluorouracil and folinic acid (NAPOLEON-2 study)

Background: Nanoliposomal irinotecan with fluorouracil and folinic acid (NFF) is a standard second- or later-line regimen for unresectable or recurrent pancreatic cancer (urPC). However, validated prognostic biomarkers are lacking. Objectives: In this study, we aimed to identify clinical predictors...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yasunori Kawaguchi, Kohei Hayashi, Mototsugu Shimokawa, Taiga Otsuka, Junichi Nakazawa, Hozumi Shimokawa, Yudai Shinohara, Futa Koga, Noriko Oza, Hisanobu Oda, Shigeyuki Takeshita, Shiho Arima, Shuji Arita, Kazuo Nishikawa, Satoshi Otsu, Hiroki Taguchi, Kenichi Jikuya, Tatsunori Sakai, Yujiro Ueda, Takahiro Sakae, Norimasa Araki, Hironori Sawase, Yasushi Ide, Machiko Kawahira, Kenta Nio, Tsuyoshi Shirakawa, Toshihiko Mizuta, Kenji Mitsugi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	SAGE Publishing 2026-04-01
coleção:	Therapeutic Advances in Medical Oncology
Acesso em linha:	https://doi.org/10.1177/17588359261442386
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!